Roden DM - Search Results

1

Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.

Strauss DG, Vicente J, Johannesen L, Blinova K, Mason JW, Weeke P, Behr ER, Roden DM, Woosley R, Kosova G, Rosenberg MA, Newton-Cheh C. Strauss DG, et al. Among authors: roden dm. Circulation. 2017 Apr 4;135(14):1300-1310. doi: 10.1161/CIRCULATIONAHA.116.023980. Epub 2017 Feb 17. Circulation. 2017. PMID: 28213480 Free PMC article.

2

Lack of triggered automaticity despite repolarization abnormalities due to bepridil and lidoflazine.

Campbell RM, Woosley RL, Iansmith DH, Roden DM. Campbell RM, et al. Among authors: roden dm. Pacing Clin Electrophysiol. 1990 Jan;13(1):30-6. doi: 10.1111/j.1540-8159.1990.tb02000.x. Pacing Clin Electrophysiol. 1990. PMID: 1689032

3

Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.

Duff HJ, Roden D, Primm RK, Oates JA, Woosley RL. Duff HJ, et al. Circulation. 1983 May;67(5):1124-8. doi: 10.1161/01.cir.67.5.1124. Circulation. 1983. PMID: 6831673 No abstract available.

4

Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes.

Gbadebo TD, Trimble RW, Khoo MS, Temple J, Roden DM, Anderson ME. Gbadebo TD, et al. Among authors: roden dm. Circulation. 2002 Feb 12;105(6):770-4. doi: 10.1161/hc0602.103724. Circulation. 2002. PMID: 11839636

5

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL Jr, Roden DM. Yang P, et al. Among authors: roden dm. Circulation. 2002 Apr 23;105(16):1943-8. doi: 10.1161/01.cir.0000014448.19052.4c. Circulation. 2002. PMID: 11997281

6

Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy.

Wu Y, Temple J, Zhang R, Dzhura I, Zhang W, Trimble R, Roden DM, Passier R, Olson EN, Colbran RJ, Anderson ME. Wu Y, et al. Among authors: roden dm. Circulation. 2002 Sep 3;106(10):1288-93. doi: 10.1161/01.cir.0000027583.73268.e7. Circulation. 2002. PMID: 12208807

7

Phosphorylation of the IKs channel complex inhibits drug block: novel mechanism underlying variable antiarrhythmic drug actions.

Yang T, Kanki H, Roden DM. Yang T, et al. Among authors: roden dm. Circulation. 2003 Jul 15;108(2):132-4. doi: 10.1161/01.CIR.0000082708.86266.B8. Epub 2003 Jun 30. Circulation. 2003. PMID: 12835205

8

Cardiovascular pharmacogenomics.

Roden DM. Roden DM. Circulation. 2003 Dec 23;108(25):3071-4. doi: 10.1161/01.CIR.0000110626.24310.18. Circulation. 2003. PMID: 14691022 No abstract available.

9

Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents.

Drolet B, Simard C, Roden DM. Drolet B, et al. Among authors: roden dm. Circulation. 2004 Jan 6;109(1):26-9. doi: 10.1161/01.CIR.0000109484.00668.CE. Epub 2003 Dec 22. Circulation. 2004. PMID: 14691044

10

Drug-induced prolongation of the QT interval.

Roden DM. Roden DM. N Engl J Med. 2004 Mar 4;350(10):1013-22. doi: 10.1056/NEJMra032426. N Engl J Med. 2004. PMID: 14999113 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

805 results

Search Page